176 related articles for article (PubMed ID: 37160922)
1. Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53.
Palanichamy JK; Tran TM; King JK; Katzman S; Ritter AJ; Sharma G; Tso C; Contreras JR; Fernando TR; Sanford JR; Rao DS
Sci Rep; 2023 May; 13(1):7490. PubMed ID: 37160922
[TBL] [Abstract][Full Text] [Related]
2. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
3. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.
DeMicco A; Yang-Iott K; Bassing CH
Cell Cycle; 2013 Oct; 12(20):3307-16. PubMed ID: 24036547
[TBL] [Abstract][Full Text] [Related]
4. Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas.
Chiang YJ; Difilippantonio MJ; Tessarollo L; Morse HC; Hodes RJ
PLoS One; 2012; 7(11):e49305. PubMed ID: 23166633
[TBL] [Abstract][Full Text] [Related]
5. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.
Adams CM; Eischen CM
Cancer Res; 2014 Jul; 74(14):3923-34. PubMed ID: 24840646
[TBL] [Abstract][Full Text] [Related]
7. Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression.
Kazantseva M; Hung NA; Mehta S; Roth I; Eiholzer R; Rich AM; Seo B; Baird MA; Braithwaite AW; Slatter TL
Sci Rep; 2017 May; 7(1):1566. PubMed ID: 28484276
[TBL] [Abstract][Full Text] [Related]
8. Development of mouse models of angiosarcoma driven by p53.
Salter DM; Griffin M; Muir M; Teo K; Culley J; Smith JR; Gomez-Cuadrado L; Matchett K; Sims AH; Hayward L; Henderson NC; Brunton VG
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31221668
[TBL] [Abstract][Full Text] [Related]
9. Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.
Gostissa M; Bianco JM; Malkin DJ; Kutok JL; Rodig SJ; Morse HC; Bassing CH; Alt FW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2934-9. PubMed ID: 23382223
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: strain differences in bone marrow tissue responses observed using microarrays.
Inoue T; Hirabayashi Y
Chem Biol Interact; 2010 Mar; 184(1-2):240-5. PubMed ID: 20018183
[TBL] [Abstract][Full Text] [Related]
11. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
12. Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation.
Amara K; Trimeche M; Ziadi S; Laatiri A; Mestiri S; Sriha B; Mokni M; Korbi S
Mod Pathol; 2008 Mar; 21(3):282-96. PubMed ID: 18165800
[TBL] [Abstract][Full Text] [Related]
13. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
14. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
16. Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.
Lee CL; Brock KD; Hasapis S; Zhang D; Sibley AB; Qin X; Gresham JS; Caraballo I; Luo L; Daniel AR; Hilton MJ; Owzar K; Kirsch DG
Cancer Res; 2021 Jul; 81(14):3777-3790. PubMed ID: 34035082
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
[TBL] [Abstract][Full Text] [Related]
18. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
[TBL] [Abstract][Full Text] [Related]
19. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
[TBL] [Abstract][Full Text] [Related]
20. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
